ACTIONABILITY KNOWLEDGE REPOSITORY ACTIONABILITY CURATION INTERFACE
Update History
Condition: Aceruloplasminemia
Gene/Gene Panel: CP
Context: Pediatric
Date
Status
Release
Outcomes-Interventions
Notes
2022/02/09
Released
1.1.5
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
Internal system migration associated with MONDO name addition.
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
CP ⇔ 0011426 ACERULOPLASMINEMIA
Strong Actionability
Strong Actionability
2022/02/09
Released (Under revision)
1.1.4
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
CP ⇔ 0011426 ACERULOPLASMINEMIA
Strong Actionability
Strong Actionability
2021/10/06
Released
1.1.4
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
CP ⇔ 0011426 ACERULOPLASMINEMIA
Strong Actionability
Strong Actionability
2021/09/15
Released (Under revision)
1.1.3
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
2020/08/19
Released
1.1.3
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
2020/08/19
Released (Under revision)
1.1.2
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
Edited MONDO ID
2020/04/29
Released
1.1.2
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
Edited MONDO ID
2020/04/29
Released (Under revision)
1.1.1
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
added MONDO ID
2020/04/22
Released
1.1.1
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
added MONDO ID
2020/04/22
Released (Under revision)
1.1.0
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/10/03
Released
1.1.0
P
Morbidity due to diabetes mellitus resulting from iron accumulation (GroupA)
Screening for diabetes mellitus (GroupA) 10CC
Morbidity due to iron accumulation (GroupA)
Iron chelation and avoidance of iron supplementation (GroupA) 8CD
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/05/16
Released
1.0.0
P
Morbidity due to diabetes mellitus resulting from iron accumulation
Screening for diabetes mellitus 10CC
Morbidity due to iron accumulation
Iron chelation and avoidance of iron supplementation 8CD
2019/04/19
In Preparation
N/A
We have begun assessment of the Pediatric context for this topic
¤ Powered by BCM's Genboree.